Zobrazeno 1 - 10
of 28
pro vyhledávání: '"J. Ziermann"'
Autor:
J Hoffmann, Sabrina Inselmann, Andreas Hochhaus, Philippe Kostrewa, Ruediger Hehlmann, Kristina Sohlbach, E. Eigendorff, Martin C. Müller, Andreas Neubauer, Andreas Burchert, J Ziermann, S K Metzelder, C. Schütz, Susanne Saussele
Publikováno v:
Leukemia. 29:1331-1335
A minority of chronic myeloid leukemia (CML) patients is capable of successfully discontinuing imatinib. Treatment modalities to increase this proportion are currently unknown. Here, we assessed the role of interferon alpha 2a (IFN) on therapy discon
Autor:
Mathias Schmidt, Andreas Hochhaus, J Ziermann, Vivien Schäfer, Alexander Kohlmann, Jenny Rinke, Thomas Ernst
Publikováno v:
Clinical Chemistry. 59:1238-1250
BACKGROUND We sought to establish a convenient, sensitive next-generation sequencing (NGS) method for genotyping the 26 most commonly mutated leukemia-associated genes in a single work flow and to optimize this method for low amounts of input templat
Autor:
H. White, F. Lin, A. Aggerholm, H. Andrikovics, G. Barbany, N. Boeckx, J. M. Cayuela, D. Colomer, F. Daraio, S. Dulucq, H. El Housni, G. Gerrard, E. Gineikiene, S. Hayette, M. Jansson, P. Johnels, T. Jurcek19, V. Kairisto20, T. Lange21, T. Lion22, K. Machova23, G. Martinelli, PA Merle, G. Mitterbauer Hohendanner, M. Nagar Marciano, J. Nomdedeu, D. A. Nymoen, E. Oppliger Leibundgut, U. Ozbek, T. Pajic, C. Preudhomme33, K. Raudsepp34, T. Sacha35, R. Talmaci36, T. Touloumenidou, VHJ Van der Velden, R. Zadro, J. Ziermann, K. Zoi, MC Müller, A. Hochhaus, NCP Cross, IZZO, BARBARA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3730::a07e071d43897f4718aad7c148a45321
http://hdl.handle.net/11588/598800
http://hdl.handle.net/11588/598800
Autor:
Martin Schmidt, Thomas Ernst, Susanne Schnittger, E Obstfelder, Andreas Hochhaus, Christa Kunert, Nils Winkelmann, Vivien Schäfer, T Haferlach, E. Eigendorff, Claudia Haferlach, Alexander Kohlmann, J Ziermann, Jenny Rinke
Publikováno v:
Leukemia. 28(12)
To study clonal evolution in chronic myeloid leukemia (CML), we searched for BCR-ABL-independent gene mutations in both Philadelphia chromosome (Ph)-negative and Ph-positive clones in 29 chronic-phase CML patients by targeted deep sequencing of 25 ge
Autor:
Jochen J. Frietsch, Peter Nollau, J Ziermann, Hardy Schweigel, Paul La Rosée, Elke Butt, Carolin Kastner, J. H. Clement, Thomas G. P. Grunewald, Andreas Hochhaus
Publikováno v:
Scopus-Elsevier
Oncotarget
Oncotarget
Chronic myeloid leukemia (CML) is characterized by a genomic translocation generating a permanently active BCR-ABL oncogene with a complex pattern of atypically tyrosine-phosphorylated proteins that drive the malignant phenotype of CML. Recently, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::279b9e51b756e445fc5038b242b4b3ac
https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/12063
https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/12063
Autor:
Thomas Ernst, J Ziermann, Susanne Schnittger, Andreas Hochhaus, Claudia Haferlach, Torsten Haferlach, Vivien Schäfer, Jenny Rinke, Nils Winkelmann, Ellen Obstfelder, Anja Waldau, Mathias Schmidt
Publikováno v:
Blood. 124:4513-4513
Molecularly defined clonal evolution has been identified as a key phenomenon in the biology of acute myeloid leukemia. Molecular aberrations may be markers of individual subclones of the disease, but also responsible for treatment resistance. In most
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.